Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing

5

XV.y Path: Respiratory bronchiolitis (w/wo the RB-ILD-pattern)

1
Last update : 11/04/2017
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Abused drugs/substances (illicit-, street drugs - IV/inhaled)
5
Cannabinoids - Cannabinoid receptor agonists (synthetic) (K2, Spice)
5
Diacetyl (2,3-butanedione) flavoring agent
3
E-cigarette's, e-vaporizer's secondhand vapor (Passive vaping)
1
Flavoring agents
5
Glue sniffing
3
Inhalants (volatile substances)
5
Marijuana, cannabis (haschish, hash, bang, dab)
5
Nicotine
1
Nitrous oxide (N2O)
1
Sildenafil
1
Tadalafil
1
Tetrahydrocannabinol (THC)
5
Tobacco smoke - Cigarette smoking
5
Vitamin E acetate (vaped, inhaled)
5

Publications

Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe.
The European respiratory journal 2020 Jul;56; 2020 Jul
Persistent Severe Fixed Airways Obstruction in a High-Dosing E-cigarette User.
Journal of general internal medicine 2020 Jan;35;345-349 2020 Jan
Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy.
Respirology case reports 2017 May;5;e00230 2017 May

Powered by

  • ^
  • Contact
  • Cookies
  • About